An A1C blood sugar test measures your average blood glucose over about the past 3 months. It is used to screen for and diagnose prediabetes or type 2 diabetes and to monitor diabetes care. Results are reported as a percentage: below 5.7% is normal, 5.7% to 6.4% suggests prediabetes, and 6.5% or higher suggests diabetes 1.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What does an A1C blood sugar test show?
A1C shows how much glucose has been attached to hemoglobin in your red blood cells. Because red blood cells live for weeks to months, the test gives a longer-term picture than a single finger-stick glucose reading 1.
Why A1C reflects average blood sugar over about 3 months
Glucose, also called blood sugar, attaches to hemoglobin, the oxygen-carrying protein inside red blood cells. When blood sugar is higher over time, more hemoglobin becomes “glycated,” so the A1C percentage rises 1.
A1C is helpful because it smooths out day-to-day swings. A single glucose reading may change after a meal, stress, illness, or exercise; A1C gives a broader view 1.
Other names for the same test
You may see this test listed as hemoglobin A1C, HbA1c, glycated hemoglobin, or glycohemoglobin. These names refer to the same basic blood test 1.
What do A1C numbers mean?
A1C ranges are used to screen for normal blood sugar, prediabetes, and diabetes. The usual cutoffs are below 5.7%, 5.7% to 6.4%, and 6.5% or higher, but one unexpected result may need confirmation 1, 2.
| A1C result | Common meaning | What to ask next |
|---|---|---|
| Below 5.7% | Generally considered normal | Ask when you should repeat testing based on age, risk factors, and symptoms. |
| 5.7% to 6.4% | Prediabetes range | Ask whether repeat testing, fasting glucose, or a plan for insulin resistance makes sense. |
| 6.5% or higher | Diabetes range | Ask whether the result should be confirmed and what type of diabetes evaluation is needed. |
A1C below 5.7%
An A1C below 5.7% is usually considered normal. It does not rule out every blood sugar problem, especially if you have symptoms or high home readings, but it is generally a reassuring result 1.
A1C from 5.7% to 6.4%
An A1C from 5.7% to 6.4% is in the prediabetes range. Prediabetes means blood sugar is higher than normal but not in the diabetes range; it is often linked with insulin resistance 1. For more background, see our guides to prediabetes and insulin resistance.
A1C of 6.5% or higher
An A1C of 6.5% or higher is in the diabetes range. In a person without clear symptoms, clinicians generally confirm the result with repeat testing or another diabetes test before making a diagnosis 1, 2.
Why diagnosis should not rely on one unexpected result
A1C can vary because of lab methods, red blood cell conditions, recent illness, and normal test variation. If your result does not fit your symptoms or home glucose readings, it is reasonable to ask whether you need a repeat A1C, fasting plasma glucose, oral glucose tolerance test, or random plasma glucose 1.
Is there a normal A1C by age?
Normal A1C cutoffs for screening and diagnosis are generally the same for adults: below 5.7% is normal, 5.7% to 6.4% suggests prediabetes, and 6.5% or higher suggests diabetes. Personal goals can differ after someone already has diabetes 1.
Why the diagnostic cutoffs are generally the same for adults
The common diagnostic categories do not use a separate “normal by age” chart for most adults. Instead, clinicians look at the A1C number, symptoms, risk factors, and whether another test confirms the pattern 1, 2.
Why personal A1C goals can differ for people already diagnosed with diabetes
After a diabetes diagnosis, an A1C goal is more personal. Age, other illnesses, low blood sugar risk, pregnancy plans, medications, and daily life all matter 1.
Why pregnancy, older age, other illnesses, and medication risks can change targets
Pregnancy needs special testing and closer clinician guidance. Later in pregnancy, clinicians usually use glucose challenge testing or oral glucose tolerance testing rather than A1C alone for gestational diabetes evaluation 1, 2.
How is A1C different from fasting blood sugar or a glucose meter reading?
A1C is a long-term average, while fasting plasma glucose, oral glucose tolerance testing, home glucose meters, and continuous glucose monitors show blood sugar at certain times. These tests can disagree because they measure different things 1.
| Test | What it shows | Fasting needed? | Common use |
|---|---|---|---|
| A1C | Average blood sugar over about 3 months | No | Screening, diagnosis, and diabetes monitoring |
| Fasting plasma glucose | Blood sugar after not eating for a set period | Yes | Screening and diagnosis |
| Oral glucose tolerance test | How blood sugar responds after a glucose drink | Usually yes | Diagnosis in select cases, including pregnancy-related testing |
| Home glucose meter | A single blood sugar reading at that moment | No, unless directed | Day-to-day monitoring |
| Continuous glucose monitor | Glucose trends across the day and night | No | Monitoring patterns, highs, lows, and time in range |
A1C vs fasting plasma glucose
Fasting plasma glucose checks your blood sugar after a fasting period. It can show a problem that A1C misses, especially if fasting sugars are high but the 3-month average looks closer to normal 1. You can compare common numbers in our normal fasting blood sugar guide.
A1C vs oral glucose tolerance test
An oral glucose tolerance test checks how your body handles a glucose drink over time. It may be used when clinicians need more detail, including in pregnancy-related diabetes testing 1.
A1C vs home glucose meter or continuous glucose monitor
A glucose meter or continuous glucose monitor can show spikes after meals, overnight lows, or patterns during exercise. A1C cannot show when highs and lows happen; it only shows the average 1. For a broader chart, see normal blood sugar levels.
Why two tests can sometimes disagree
Two tests can disagree if your blood sugar changes a lot during the day, if you recently changed habits or medications, or if a condition affects red blood cells. In that case, a clinician may compare A1C with fasting glucose, glucose meter data, or an oral glucose tolerance test 1.
How do you get an A1C test?
A1C testing can be done through a lab blood draw, a point-of-care finger-prick test, or some at-home test kits. When diabetes diagnosis is being considered, lab-based testing is usually preferred 1.
Lab blood draw from a vein
A lab blood draw is the usual choice when a clinician is screening for or diagnosing prediabetes or diabetes. NIDDK notes that A1C tests used for diagnosis should use methods certified by the NGSP, a program that standardizes A1C testing 1.
Point-of-care finger-prick tests
Point-of-care A1C tests can give results during a visit. They can be useful for monitoring, but a clinician may still order lab testing if the result is unexpected or if diagnosis is being considered 1.
At-home A1C test kits: what they can and cannot tell you
At-home A1C kits may help some people track trends. They should not replace clinician-directed diagnostic testing if you have symptoms, are pregnant, or have a result in the prediabetes or diabetes range.
Why lab-based testing is preferred for diagnosis
Diagnosis has real health and insurance consequences, so accuracy matters. Lab-based testing also gives your clinician a clearer record if repeat testing or another glucose test is needed 1.
When should someone ask a clinician about A1C testing?
A1C screening is worth discussing if you are 45 or older, have overweight or obesity plus risk factors, had gestational diabetes, or have symptoms of high blood sugar. Repeat testing depends on your result and risk level 1, 2.
Adults age 45 and older
Many adults start diabetes screening around age 45. If results are normal, your clinician can tell you how often to repeat testing based on your risk factors 2.
Adults under 45 with overweight or obesity plus risk factors
Screening may be considered earlier for adults with overweight or obesity plus risk factors such as family history, high blood pressure, abnormal cholesterol, or signs of insulin resistance 2.
History of gestational diabetes
A history of gestational diabetes raises the chance of later type 2 diabetes. Postpartum and long-term screening should be guided by a clinician 2, 5.
Symptoms that may suggest high blood sugar
Symptoms such as extreme thirst, frequent urination, unexplained weight loss, blurry vision, fatigue, nausea, vomiting, confusion, dehydration, or rapid breathing need prompt medical advice. Severe symptoms can be urgent.
How often repeat testing may be recommended
If A1C is normal, repeat testing may be spaced out. If it is in the prediabetes or diabetes range, clinicians often repeat sooner or add another test, depending on symptoms and context 1, 2.
3-min quiz
Considering weight loss as part of a metabolic health plan?
Weight loss can be one part of a clinician-guided plan for some adults with insulin resistance or prediabetes. Chia offers online eligibility review for compounded semaglutide injection and compounded tirzepatide tablets or injections, when clinically appropriate. A prescription requires review by a licensed US provider and is not guaranteed. Compounded drugs are not FDA-approved.
What can make an A1C result inaccurate?
A1C accuracy depends partly on red blood cells and hemoglobin. Conditions that change red blood cell lifespan or hemoglobin structure can make A1C look higher or lower than your true glucose pattern 1.
Hemoglobin variants, sickle cell trait, and thalassemia
Some people have hemoglobin variants, including sickle cell trait or thalassemia traits, that can interfere with certain A1C methods. NIDDK notes that ancestry and family history can matter because some variants are more common in people with African, Mediterranean, South or Southeast Asian, or other ancestries 1.
Recent blood loss, transfusion, anemia, kidney disease, and other conditions
Recent blood loss, blood transfusion, some anemias, kidney disease, liver disease, and other conditions can affect A1C. If your A1C does not match glucose meter or continuous glucose monitor readings, your clinician may use another test 1.
Why ancestry and family history can matter
Family history can point to hemoglobin variants or inherited blood conditions. If these run in your family, tell your clinician before relying on A1C alone 1.
What to ask if A1C does not match glucose readings
Ask whether the lab used an NGSP-certified method, whether a hemoglobin variant could affect the result, and whether fasting plasma glucose, oral glucose tolerance testing, fructosamine, or glucose monitoring would give a clearer picture 1.
How can A1C be lowered safely?
Lowering A1C safely usually means improving average blood sugar over weeks to months, not overnight. Food patterns, activity, sleep, weight changes, diabetes education, and medications may all play a role depending on the person 3, 6, 7.
Why there is no safe overnight fix for A1C
A1C reflects about 3 months of blood sugar, so rapid changes may not show fully right away. Trying to lower glucose too fast without guidance can be risky, especially for people using insulin or medicines that can cause low blood sugar 1, 3.
Food patterns, physical activity, sleep, and weight changes
For many people, the strongest first steps are steady: eating patterns that reduce glucose spikes, regular movement, better sleep, and weight loss when appropriate. Weight loss can improve insulin resistance for some people with prediabetes, but the right plan depends on health history and medications 2. See our guide to weight loss for prediabetes.
Diabetes education and self-management support
Education and support can help people understand meals, activity, monitoring, medications, and warning signs. Human trials have studied diabetes education, text-message reminders, culturally tailored self-care support, and group visits for improving diabetes management and metabolic outcomes 6, 7, 8.
Medication options a clinician may consider when appropriate
Medication choices depend on the diagnosis, A1C level, kidney function, heart risk, weight goals, pregnancy status, cost, side effects, and low blood sugar risk. Comparative-effectiveness research has evaluated several glucose-lowering options added to metformin, including a GLP-1 receptor agonist, basal insulin, a DPP-4 inhibitor, and a sulfonylurea 3, 4.
Semaglutide is a GLP-1 receptor agonist known by brand names such as Wegovy and Ozempic; tirzepatide is a dual GIP/GLP-1 receptor agonist known by brand names such as Zepbound and Mounjaro. These drugs can cause side effects such as nausea, vomiting, diarrhea, constipation, and abdominal pain, and they are not appropriate for everyone, including some people with certain endocrine cancer histories or pancreatitis risk factors; a clinician should review risks and alternatives 9, 10.
When to seek urgent care for possible severe high blood sugar
Seek urgent care if you have severe dehydration, confusion, vomiting, rapid breathing, severe weakness, or very high glucose readings with symptoms. These can be signs of a serious high-blood-sugar emergency.
Which next step fits which A1C situation?
Next steps depend on the result, symptoms, pregnancy status, and whether the test fits the full picture. The table below is a starting point for what to ask, not a diagnosis.
| Your situation | Sensible next step | Why it matters |
|---|---|---|
| A1C below 5.7% and no symptoms | Ask when to repeat based on risk. | A normal result is reassuring, but screening timing still depends on age and risk factors. |
| A1C 5.7% to 6.4% | Ask about repeat testing, fasting glucose, insulin resistance, nutrition, activity, sleep, and weight if relevant. | Prediabetes is a chance to act early with clinician guidance. |
| A1C 6.5% or higher without symptoms | Ask whether the result needs confirmation. | Diagnosis usually should not rest on one unexpected lab result. |
| A1C result does not match home readings | Ask about A1C accuracy and other tests. | Hemoglobin variants or red blood cell conditions can affect A1C. |
| Pregnant or recently pregnant | Ask an obstetric or diabetes clinician which glucose test is right. | Pregnancy often needs different testing and targets. |
| High blood sugar symptoms or severe illness | Seek prompt medical care. | Severe hyperglycemia can become urgent. |
When weight loss is part of an A1C plan, what can Chia offer?
Chia can help eligible adults explore prescription weight-loss treatment when weight is part of a clinician-guided metabolic health plan. We do not diagnose diabetes from an article, and a prescription is never guaranteed.
At Chia, treatment starts 100% online with a short health questionnaire. A licensed US provider reviews your information and prescribes only when clinically appropriate. Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door.
For weight-loss care, Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injections. Semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual GIP/GLP-1 receptor agonist. Brand-name examples include Wegovy and Ozempic for semaglutide and Zepbound and Mounjaro for tirzepatide, but compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
| Chia option | Forms Chia offers | Current starting price | Notes |
|---|---|---|---|
| Compounded semaglutide | Injection | Plans currently start at $249/mo | Provider-guided dosing; microdosing plans available when clinically appropriate. |
| Compounded tirzepatide | Tablets or injection | Tablets from $249/mo; injection from $299/mo | Provider-guided dosing; microdosing plans available when clinically appropriate. |
| Weight + Energy protocol | NAD+ injection plus choice of GLP-1 | Plans currently start at $309/mo | May fit adults who want weight-loss treatment plus an energy-focused protocol after provider review. |
Some adults ask about microdosing GLP-1 therapy for metabolic goals. Chia offers microdosing plans for semaglutide and tirzepatide when a provider decides it is clinically appropriate; compounded formulations and microdosing uses are not FDA-approved. You can also read our article on microdosing tirzepatide.
Chia may fit adults seeking weight-loss care, but it is not the right place for urgent symptoms, pregnancy-related glucose concerns, suspected type 1 diabetes, or severe hyperglycemia. Those situations need timely in-person or specialty medical care.
What should you ask your clinician after an A1C result?
After an A1C result, the best question is not just “Is this good or bad?” It is “What does this mean for me, and what should we check next?”
- Do I need a repeat A1C or another test to confirm this result?
- Should I also check fasting plasma glucose, oral glucose tolerance testing, random plasma glucose, or home readings?
- Could anemia, kidney disease, a hemoglobin variant, recent blood loss, transfusion, or pregnancy affect my result?
- What is my personal A1C goal if I already have diabetes?
- What food, activity, sleep, weight, or medication changes are safest for my health history?
- What symptoms should make me seek urgent care?
3-min quiz
Start a clinician-reviewed weight-loss visit
If weight loss is part of your metabolic health plan, Chia can help you explore whether compounded semaglutide, compounded tirzepatide, or the Weight + Energy protocol fits your goals. A licensed US provider reviews your health history first, and prescribing is not guaranteed. Compounded medications are not FDA-approved.
FAQ
For most adults, the common diagnostic cutoff for normal A1C is below 5.7%, regardless of age. Personal A1C goals can differ for people who already have diabetes, especially with pregnancy, older age, other illnesses, or medications that can cause low blood sugar 1.
Some people feel no symptoms. Others may notice thirst, frequent urination, blurry vision, fatigue, unexplained weight loss, or slow-healing infections. Severe symptoms such as vomiting, confusion, dehydration, or rapid breathing need urgent medical care 1.
Some at-home A1C kits are available and may help with tracking trends. If diabetes is suspected, a clinician-directed lab test is preferred for diagnosis, especially if the result is unexpected, you have symptoms, or you are pregnant 1.
No. A1C does not usually require fasting. Fasting may be needed if your clinician orders other labs at the same time, such as fasting plasma glucose or cholesterol testing 1.
Yes. A1C is an average, so it may miss short spikes after meals or overnight changes. A glucose meter or continuous glucose monitor can show timing and patterns that A1C cannot 1.
In studies of active ingredients such as semaglutide and tirzepatide, GLP-1 and GIP/GLP-1 medications have been studied for blood sugar and weight effects in specific populations. Results are not established for compounded formulations, and compounded drugs are not FDA-approved. A clinician should decide whether these medications fit your health history.
References
- 1.National Institute of Diabetes and Digestive and Kidney Diseases. The A1C Test & Diabetes. NIDDK, accessed 2026.
- 2.StatPearls. Management of Cardiovascular and Diabetes Risks Based on National Guidelines. StatPearls Publishing, 2023.
- 3.National Institute of Diabetes and Digestive and Kidney Diseases. Limited Competition: Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study (U01). NIH Grants, 2016.
- 4.Agency for Healthcare Research and Quality. Diabetes Medications for Adults With Type 2 Diabetes: An Update. NCBI Bookshelf, 2016.
- 5.Juliusdottir TJ, Hrafnkelsson H, Bjarnadottir RI, et al. Prescribing physical activity after labour, for women diagnosed with gestational diabetes mellitus. Laeknabladid, 2019.
- 6.Güner TA, Coşansu G. The effect of diabetes education and short message service reminders on metabolic control and disease management in patients with type 2 diabetes mellitus. Primary Care Diabetes, 2020.
- 7.Williams IC, Utz SW, Hinton I, et al. Enhancing diabetes self-care among rural African Americans with diabetes: results of a two-year culturally tailored intervention. The Diabetes Educator, 2014.
- 8.Baig AA, Staab EM, Benitez A, et al. Impact of diabetes group visits on patient clinical and self-reported outcomes in community health centers. BMC Endocrine Disorders, 2022.
- 9.Novo Nordisk. Wegovy (semaglutide) injection prescribing information. FDA label, accessed 2026.
- 10.Eli Lilly and Company. Zepbound (tirzepatide) injection prescribing information. FDA label, accessed 2026.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
